Swiftscale Biologics
Synthetic biology company developing vaccines and therapeutics using cell-free biology technology
All edits
Edits on 5 Apr, 2023
Katrina-Kay Pettitt
Edits on 30 Mar, 2023
' fill='white' fill-rule='nonzero'%3e%3cpath d='M52 12c-22.048 0-40 17.952-40 40 0 10.848 4.48 21.376 12.288 28.864 7.008 6.752 16.096 10.592 25.792 11.04.48.032.992.096 1.472.096H52c10.336 0 20.128-3.904 27.616-11.04C87.616 73.312 92 63.04 92 52c0-22.048-17.952-40-40-40zm26.912 65.056c-1.472-5.216-8.448-8.032-13.696-10.112l-1.792-.736C60 64.8 60 63.488 60 61.6c0-1.344.672-3.264 1.888-4.416 3.104-2.72 4.736-6.464 4.736-10.816 0-8.8-6.144-15.168-14.624-15.168-8.448 0-14.336 6.24-14.336 15.168 0 4.544 1.536 8.192 4.512 10.816 1.248 1.12 1.792 3.072 1.792 4.416 0 1.344 0 3.008-4.16 4.704-5.12 2.112-11.904 4.992-15.008 10.432C18.688 69.984 15.2 61.12 15.2 52c0-20.288 16.512-36.8 36.8-36.8 20.288 0 36.8 16.512 36.8 36.8 0 9.408-3.52 18.208-9.888 25.056z'/%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
Deactivated User
Infobox
Industry
Edits on 17 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 23 Feb, 2023
Katrina-Kay Pettitt
Edits on 5 Nov, 2022
Semyon Kolychev
Edits made to:
Infobox (+1 properties)
Infobox
Glassdoor ID
3193583
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Competitors
Edits on 20 May, 2022
Ирина Носкова
Edits made to:
Infobox (+1 properties)
Infobox
Company Operating Status
Active
Edits on 30 Apr, 2022
Ekaterine Dadiani
Edits on 11 May, 2021
Edits on 6 Oct, 2020
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Latest funding round date
June 1, 2020
Edits on 24 Aug, 2020
Aleksander Holm
Edits made to:
Infobox (--2 properties)
Infobox
Business model
CommerceLicensing
Edits on 4 Aug, 2020
Marie G Bedia
Edits on 31 Jul, 2020
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Total funding amount (USD)
10,500,000
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Edits on 28 Jul, 2020
Marie G Bedia
Edits on 30 Apr, 2020
Nico Faraguna
Edits on 19 Mar, 2020
Aime Anne Nisay
Edits made to:
Article (+21/-21 characters)
Article
Swiftscale is developing a vaccine to Shigella bacteria which is a leading cause of diarrhea and a neutralizing antibodyneutralizing antibody that can serve as a treatment for COVID-19. Neutralizing antibodies treat infectious diseases by binding to viral or bacterial protein, blocking their interaction with host cells.
Find more companies like Swiftscale Biologics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
